UnitedHealth Group Stock Holds Steady Near $375 Amid Robust Profit Expectations
UnitedHealth Group stock has remained steady near $375 after closing on September 16, 2026. Despite being below its July 2026 52-week high of $461.62, the company's robust profit expectations have been underscored by Zacks' adjusted EPS guidance for fiscal 2026.
According to Zacks, UnitedHealth Group now targets adjusted earnings per share (EPS) of $19.50 to $20.00 for 2026. This is a key valuation anchor for investors, reflecting confidence in medical-cost management and growth across the company's insurance and healthcare services operations.
The Q2 2026 results showed revenue of $112.03 billion and earnings of $5.48 billion. Zacks highlighted that operating cash flow in the first half of 2026 increased by 57.9% year on year, signaling stronger cash generation to support dividends, share repurchases, and strategic investments.
Analyst commentary remains broadly constructive on UnitedHealth Group, with an Outperform recommendation from Zacks pointing to attractive growth prospects and upside potential from current levels. However, the analyst also emphasizes that medical-cost trends are central to the investment case, as improved cost ratios have helped underpin recent performance.